Skip to main content
. 2020 Jul 22;12(8):2180. doi: 10.3390/nu12082180

Figure 2.

Figure 2

Repression of muscle atrophy by β-cryptoxanthin in the soleus muscle of SAMP1 mice. (A) Immunofluorescent staining of laminin in the soleus muscle of the SAMR1 (R1), SAMP1-control (P1con), and SAMP1-CX (P1cx) groups. Scale bar: 100 μm. (B) Distribution of soleus muscle fiber cross-sectional area (CSA). (C) Average size of the soleus muscle fiber CSA. (D) Western blot analyses of MyHC type I and GAPDH. MyHC type I expression was normalized to anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression. Values are represented as mean ± standard deviation. n = 5–8 per group. * p < 0.05, statistical significance compared with the SAMP1-control group.